Home > M&A deals 2006 > BAML Capital Partners acquires Tongjitang Chinese Medicines Company
Transaction · Life Science · January 2006

BAML Capital Partners acquires Tongjitang Chinese Medicines Company

On January 1, 2006, BAML Capital Partners acquired Tongjitang Chinese Medicines Company, a life science company in China.

Deal at a glance

AnnouncedJanuary 1, 2006 TargetTongjitang Chinese Medicines Company Buyer BAML Capital Partners SectorLife Science LocationChina ValueNot disclosed

Target company

Tongjitang Chinese Medicines Company
China
Life Sciencesector
-founded
Activestatus
View the company profile →

Buyer

BAML Capital Partners
Private equity firm · 67 deals on record
  • 2nd transaction in life science
  • 1st transaction in China
67deals, all time
2in this sector
2010latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

ZhengZhou Fortune Bioscience Co., Ltd.Same sector and country · Feb 2022

Questions about this deal

Who acquired Tongjitang Chinese Medicines Company?BAML Capital Partners acquired Tongjitang Chinese Medicines Company on January 1, 2006.

What type of deal was it?It was a transaction in the life science sector in 2006.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).